Flt3L -expanded conventional type I dendritic cells formed in the tumor prime “stem-like” T cells in the draining lymph nodes to evoke enhanced responses to immunotherapy [1]
RNA-seq (gene expression) · mouse · 10 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 10 samples: 5 × 24JK Tumors (Day16) vs 5 × 24JK-FLT3L Tumors (Day16)Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8(+) T cells in lymph nodesNature immunology · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE291668_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1234612 and SRA study SRP569722. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 10 samples.
How we read this: 2 replicated groups read from 10 sample titles; they account for 10 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8839577 24JK Tumors (Day16) rep 1 24JK Tumors (Day16)
- GSM8839578 24JK Tumors (Day16) rep 2 24JK Tumors (Day16)
- GSM8839579 24JK Tumors (Day16) rep 3 24JK Tumors (Day16)
- GSM8839580 24JK Tumors (Day16) rep 4 24JK Tumors (Day16)
- GSM8839581 24JK Tumors (Day16) rep 5 24JK Tumors (Day16)
- GSM8839582 24JK-FLT3L Tumors (Day16) rep 1 24JK-FLT3L Tumors (Day1…
- GSM8839583 24JK-FLT3L Tumors (Day16) rep 2 24JK-FLT3L Tumors (Day1…
- GSM8839584 24JK-FLT3L Tumors (Day16) rep 3 24JK-FLT3L Tumors (Day1…
- GSM8839585 24JK-FLT3L Tumors (Day16) rep 4 24JK-FLT3L Tumors (Day1…
- GSM8839586 24JK-FLT3L Tumors (Day16) rep 5 24JK-FLT3L Tumors (Day1…
- GSE283198 Combined Flt3L and CD40 agonism restores dendritic cell driven T cell immunity in mouse models and patients with pancreatic cancer [mouse] 13 samples shares flt3l, dendritic
- GSE280985 An immunobiliary single-cell atlas resolves crosstalk between type 2 conventional dendritic cells and γδ T cells in cholangitis [scRNA-seq] 14 samples shares conventional, dendritic
- GSE326309 Cohesin complex cooperates with PU.1 at super-enhancers to regulate the differentiation and identity of conventional dendritic cells 34 samples shares conventional, dendritic
- GSE249630 Modeling T cell temporal response to cancer immunotherapy rationalize development of combinatorial treatments protocols 1372 samples shares immunotherapy
- GSE302715 A tumor-associated macrophage-targeted immunocytokine leveraging T and NK cell synergy for potent cancer immunotherapy [scRNA-seq] 187 samples shares immunotherapy
- GSE293874 Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity [mouse bulk RNA-seq] 167 samples shares dendritic
- GSE342349 CT26 multi-tissue RNA-seq under immunotherapy combinations 72 samples shares immunotherapy
- GSE244034 Tumor-targeting oncolytic viruses engineered for glioblastoma immunotherapy 48 samples shares immunotherapy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.